Related Experiment Video
Updated: Jul 13, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Masked hypertension in diabetes mellitus: a potential risk
Kazuo Eguchi1, Joji Ishikawa, Satoshi Hoshide
1Center for Behavioral Cardiovascular Health, Columbia University Medical Center, New York, NY 10032, USA. ke2126@columbia.edu
Abstract:
The prevalence and clinical significance of masked hypertension (MHT) in diabetics have infrequently been described. The authors assessed the association of MHT (defined using a clinic blood pressure [BP] <140/90 mm Hg and daytime ambulatory BP > or = 135/85 mm Hg) with microvascular and macrovascular end organ damage in 81 clinically normotensive Japanese diabetic persons. The prevalence of silent cerebral infarcts (SCIs), increased left ventricular mass, and albuminuria were evaluated. Of 81 patients, 38 (46.9%) were classified as having MHT and showed significantly more SCIs (mean +/- SE: 2.5+/-0.5 vs 1.1+/-0.2; P=.017), and more albuminuria (39% vs 16%; P=.025), but no increase in left ventricular mass index, than the normotensive persons in office and on ambulatory BP monitoring group. The prevalence of MHT in this diabetic population was high (47%). Diabetic patients with MHT showed evidence of brain and kidney damage. Hence, out-of-office monitoring of BP may be indicated in diabetics whose BP is normal in the clinic.
Insights
Masked hypertension (high blood pressure outside the clinic) is common in diabetics. This condition is linked to increased risks of brain and kidney damage, suggesting the need for regular blood pressure monitoring.
Area of Science:
- Cardiology
- Nephrology
- Neurology
Background:
- Masked hypertension (MHT) prevalence and clinical significance in diabetic patients are not well-documented.
- MHT is defined as clinic blood pressure <140/90 mm Hg and daytime ambulatory blood pressure ≥135/85 mm Hg.
- Diabetic individuals with normal clinic blood pressure may still have elevated readings outside the clinical setting.
Purpose of the Study:
- To assess the association between MHT and end-organ damage in Japanese diabetic patients.
- To determine the prevalence of MHT in a cohort of clinically normotensive diabetic individuals.
- To evaluate microvascular and macrovascular complications, including silent cerebral infarcts (SCIs), left ventricular mass, and albuminuria.
Main Methods:
- A study involving 81 Japanese diabetic patients with normal clinic blood pressure.
- Classification of patients into MHT and normotensive groups based on clinic and 24-hour ambulatory blood pressure monitoring.
- Evaluation of silent cerebral infarcts (SCIs), left ventricular mass index, and albuminuria as indicators of end-organ damage.
Main Results:
- The prevalence of MHT was high, affecting 46.9% of the studied diabetic population.
- Patients with MHT exhibited significantly higher rates of SCIs (2.5 vs 1.1) and albuminuria (39% vs 16%) compared to normotensive diabetics.
- No significant difference in left ventricular mass index was observed between the MHT and normotensive groups.
Conclusions:
- Masked hypertension is prevalent in Japanese diabetic patients and is associated with significant brain and kidney damage.
- These findings highlight the clinical importance of out-of-office blood pressure monitoring in diabetic individuals.
- Regular ambulatory blood pressure monitoring may be crucial for identifying MHT and preventing complications in diabetics with normal clinic BP readings.
Related Concept Videos
Diabetic Retinopathy
Hypoglycemia
Diabetic Nephropathy
Hyperglycemia
Diabetes: Symptoms, Diagnosis, and Complications
Hypertension III: Clinical Manifestations and Diagnostic Studies

